Equities

Yabao Pharmaceutical Group Co Ltd

600351:SHH

Yabao Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)6.13
  • Today's Change0.03 / 0.49%
  • Shares traded6.08m
  • 1 Year change-13.90%
  • Beta1.2928
Data delayed at least 15 minutes, as of May 31 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.

  • Revenue in CNY (TTM)2.88bn
  • Net income in CNY204.43m
  • Incorporated1999
  • Employees4.14k
  • Location
    Yabao Pharmaceutical Group Co LtdNo.1Gongye BoulevardFenglingdu Economic Development ZoneBEIJING 100176ChinaCHN
  • Phone+86 1 057809936
  • Fax+86 1 057809937
  • Websitehttp://www.yabao.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jinyao Pharmaceutical Co Ltd3.66bn107.59m4.32bn2.68k40.131.43--1.180.09840.09843.352.760.57382.289.371,365,219.002.331.914.173.4042.6146.334.063.310.758427.180.206444.402.559.28230.60-4.22-9.589.21
Shanghai OPM Biosciences Co Ltd254.91m49.43m4.33bn285.0087.822.01--16.980.42940.42942.2218.800.10952.072.54894,431.902.094.342.164.6558.8658.3119.0623.4019.91--0.031545.38-17.4148.34-48.72--6.09--
Assure Tech Hangzhou Co Ltd511.29m160.91m4.39bn791.0027.310.8485--8.601.271.274.0240.750.07991.522.67646,379.602.5131.832.9438.9738.5665.8231.4747.868.26--0.016616.05-91.8425.18-95.3533.5178.77--
Yabao Pharmaceutical Group Co Ltd2.88bn204.43m4.41bn4.14k22.261.51--1.530.27540.27543.814.050.71932.986.79695,432.104.522.825.903.9756.0059.206.294.191.6247.130.067543.747.05-0.057290.71-6.107.98-9.71
Shanghai Medicilon Inc1.17bn-172.33m4.44bn2.60k--1.80--3.78-1.24-1.249.1118.340.42056.631.64451,437.20-6.179.34-7.9711.7312.4836.71-14.6814.932.63--0.122920.18-17.6833.26-109.82--23.60--
Hainan Huluwa Pharmaceutical Grop Co Ltd1.81bn94.97m4.46bn2.47k46.933.88--2.460.23740.23744.522.870.67212.883.81732,708.903.805.816.299.7850.3358.015.667.030.82457.040.524621.7425.7514.1324.291.1646.37--
Shanghai Haoyuan Chemexpress Co Ltd1.97bn97.97m4.53bn3.37k46.161.78--2.300.6520.65213.1016.920.48451.013.91583,547.802.387.383.239.6042.5147.034.9213.530.8943.370.301314.3738.4444.33-34.1847.2448.95--
Beijing Konruns Pharmaceutical Co Ltd954.14m166.44m4.53bn447.0026.721.43--4.751.061.066.0519.780.25482.503.732,134,547.005.465.436.396.2488.2989.9321.4420.763.08--0.048621.536.15-2.0848.24-10.6343.05-9.71
Data as of May 31 2024. Currency figures normalised to Yabao Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.39%Per cent of shares held by top holders
HolderShares% Held
China Universal Asset Management Co., Ltd.as of 31 Dec 20233.15m0.41%
The Vanguard Group, Inc.as of 30 Apr 20242.47m0.32%
Penghua Fund Management Co., Ltd.as of 31 Dec 20231.39m0.18%
Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 20231.08m0.14%
Wanjia Asset Management Co., Ltd.as of 31 Dec 2023747.90k0.10%
Broad Fund Management Co. Ltd.as of 31 Dec 2023575.30k0.08%
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023509.00k0.07%
Bosera Asset Management Co., Ltd.as of 31 Dec 2023372.70k0.05%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023240.40k0.03%
Baoying Fund Management Co., Ltd.as of 31 Dec 2023165.40k0.02%
More ▼
Data from 30 Jun 2023 - 22 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.